The growth response to tumour necrosis factor α of human gynaecological cancer cell lines

Cytokine

Volumn 10, Issue 6, 1998, Pages 432-440

  Beesley, J S ^a   Kirby, P L ^a   Takeda, S ^b   Stackpoole, A ^a   Soutter, W P ^b   White, J O ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Gynaecological cancer cell lines; HOG 1; TNF

Indexed keywords

CELL SURFACE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 0032103014     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.9997     Document Type: Article

References (36)

1. 1. Fiers W (1991) Tumour necrosis factor - characterisation at the molecular, cellular and in vivo level. Febs Lett 285:199-212.
2. 2. Beyaert R, Fiers W (1994) Molecular mechanisms of tumour necrosis factor-induced cytotoxicity. Febs Lett 340:9-16.
3. 3. Brockhaus M, Shoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H (1990) Identification of two types of tumour necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127-3131.
4. 4. Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W (1990) Molecular cloning and expression of the human 55 kd tumour necrosis factor receptor. Cell 61:351-359.
5. 5. Schall TJ, Lewis M, Koller KJ, Lee A, Rich GC, Wong GH, Gatanga T, Granger GA, Lentz R, Raab H, Kohr WJ, Goeddel DV (1990) Molecular cloning and expression of a receptor for human tumour necrosis factor. Cell 61:361-367.
6. 6. Dembic Z, Loetscher H, Gubler U, Pan YC, Lahm HW, Gentz R, Brockhaus M, Lesslauer W (1990) Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 2:231-237.
7. 7. Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959-962.
8. 8. Marsters SA, Frutkin AD, Simpson NJ, Fendly BM, Ashkenazi A (1992) Identification of cysteine-rich domains of the type 1 tumour necrosis factor receptor involved in ligand binding. J Biol Chem 267:5747-5750.
9. 9. Chen P, C-H Dubois GC, Chen M-J (1995) Mapping of the domain(s) critical for the binding of human tumour necrosis factor-α to its two receptors. J Biol Chem 270:2874-2878.
10. 10. Adolph GA, Grell M, Scheurich P (1994) Tumour necrosis factor. In Luger TA and Schwartz T, (eds), Epidermal Growth Factors and Cytokines (New York: Marcel Dekker, Incorporated) pp. 63-88.
11. 11. Schalaby MR, Sundan A, Loetscher H, Brockhaus M, Lesslauer W, Espevik T (1990) Binding and regulation of cellular functions by monoclonal antibodies against human tumour necrosis factors. J Exp Med 172:1517-1520.
12. 12. Hohmann HP, Remy R, Brockhaus M, Van Loon A (1989) Two different cell types have different major receptors for human tumour necrosis factor (TNF alpha). J Biol Chem 264:14927-14934.
13. 13. Abe Y, Osuka Y, Nakata T, Kashu Y, Kimura S (1995) The functional role of 55- and 75-kDa tumour necrosis factor receptors in human polymorphonuclear cells in vitro. Cytokine 7:39-49.
14. 14. Tartaglia LA, Pennica D, Goeddel DV (1993) Ligand passing: the 75-kDa tumour necrosis factor (TNF) receptor recruits TNF for signalling by the 55-kDa TNF receptor. J Biol Chem 268:18542-18548.
15. 15. Vadenabeele P, Declercq W, Vercammen D, Van de Craen M, Grooten J, Loetscher H, Brockhaus M, Lesslauer W, Fiers W (1992) Functional characterisation of the human tumour necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma. J Exp Med 176:1015-1024.
16. 16. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P (1995) The transmembrane form of tumour necrosis factor alpha is the prime activating ligand of the 80kDa tumour necrosis factor receptor. Cell 83:793-802.
17. 80, are involved in signaling endothelial tissue factor expression by juxtacrine tumour necrosis factor α. Blood 86:123-132.
18. 18. Lewis GD, Aggarwal BB, Eessalu TE, Sugarman BJ, Shepard HM (1987) Modulation of the growth of transformed cells by human tumour necrosis factor-α and interferon-γ. Cancer Res 47:5382-5385.
19. 19. Mutch DG, Massad LS, Kao M-S, Collins JS (1990) Proliferative and antiproliferative effects of interferon-γ and tumour necrosis factor-α on cell lines derived from cervical and ovarian malignancies. Am J Obstet Gynecol 163:1920-1924.
20. 20. Nishikawa K, Rosenblum MG, Newman RA, Pandita TK, Hittelman WN, Donate NJ (1992) Resistance of human cervical carcinoma cells to tumour necrosis factor correlates with their increased sensitivity to cisplatin: Evidence of a role for DNA repair and epidermal growth factor receptor. Cancer Res 52:4758-4756.
21. 21. Manchester KM, Heston WDW, Donner DB (1993) Tumour necrosis factor-induced cytotoxicity is accompanied by intracellular mitogenic signals in ME-180 human cervical carcinoma cells. Biochem J 290:185-190.
22. 22. Woodworth CG, McMullin E, Iglesias M, Plowman GD (1995) Interleukin 1α necrosis factor α stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc Natl Acad Sci USA. 92:2840-2844.
23. 23. Berchuck A, Kohler MF, Boente MP, Rodriguez GC, Whitaker RS, Bast RC (1993) Growth regulation and transformation of ovarian epithelium. Cancer 71:545-551.
24. 24. Wu S, Boyer CM, Whitaker RS, Berchuck A, Wiener JR, Weinberg JB, Bast RC (1993) Tumour necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer. Cancer Res 53:1939-1944.
25. 25. Tabibzadeh S, Zupi E, Babaknia A, Liu R, Marconi D, Romanini C (1995) Site and menstrual cycle dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNF alpha in human endometrium. Human Reproduction 10:277-286.
26. 26. Tabibzadeh S (1991) Ubiquitous expression of TNF alpha/Cachectin in human endometrium. Am J Reprod Immunol 26:1-5.
27. 27. Philippaeaux M-M, Piguet PE (1993) Expression of tumour necrosis factor alpha and its mRNA in the endometrial mucosa during the menstrual cycle. Am J Pathol 143:480-486.
28. 28. Croxtall JD, Elder MG, WHITE JO (1990) Hormonal control of proliferation in the Ishikawa endometrial adenocarcinoma cell line. J Steroid Biochem 35:665-669.
29. 29. Tavernier J, Van Ostade X, Hauquier G, Prange T, Lasters I, MM de, Lewit BA, Fourme R (1989) Conserved residues of tumour necrosis factor and lymphotoxin constitute the framework of the trimeric structure. Febs Lett 257:315-318.
30. 30. Barbara JAJ, Smith WB, Gamle JR, Ostade XV, Vandenabeele P, Tavernier J, Fiers W, Vadas MA, Lopez AF (1994) Dissociation of TNF-α cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-α mutants. EMBO J 13:843-850.
31. 31. Spriggs D, Imamura K, Rodriguez C, Horiguchi J, Kufe DW (1987) Induction of tumour necrosis factor expression and resistance in a human breast tumour cell line. Proc Natl Acad Sci USA 84:6563-6566.
32. 32. Okamoto T, Watanabe N, Yamauchi N, Tsuji Y, Tsuji N, Itoh Y, Neda H, Niitsu Y (1992) Endogenous tumour necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous tumour necrosis factor. Cancer Res 52:5278-5281.
33. 33. Van Ostade X, Vandenabeele P, Everaerdt B, Loetscher H, Gemtz R, Brockhaus M, Lesslauer W, Tavernier J, Brouckaert P, Fiers W (1993) Human TNF mutants with selective activity on the p55 receptor. Nature 361:266-269.
34. 34. Schwalb DM, Han H, Marino M, Warren R, Porter A, Goh C, Fair WR, Donner DB (1993) Identification of a new receptor subtype for tumour necrosis factor-alpha. J Biol Chem 268: 9949-9952.
35. 35. White JO, Jones RN, Croxtall JD, Gleeson RP, Krausz T, Pervez S, Jamil A, Guida L, Beesley JS, Soutter WP (1992) The human squamous cervical carcinoma cell line, HOG-1, is responsive to steroid hormones. Int J Cancer 52:247-251.
36. 36. Labarca C, Paigen K (1980) A simple, rapid and sensitive DNA assay procedure. Anal Biochem 102:344-352.